Cargando…
Ototoxicity from Combined Cisplatin and Radiation Treatment: An In Vitro Study
Objective. Combined cisplatin (CDDP) and radiotherapy is increasingly being used to treat advanced head and neck cancers. As both CDDP and radiation can cause hearing loss, it is important to have a better understanding of the cellular and molecular ototoxic mechanisms involved in combined therapy....
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995915/ https://www.ncbi.nlm.nih.gov/pubmed/21151649 http://dx.doi.org/10.1155/2010/523976 |